In this Q&A, Dr Machado answers our questions about the impact that biologic disease-modifying antirheumatic drugs have in axial spondyloarthritis remission.
Transferring a patient with a rheumatic condition from pediatric care to adult care comes with challenges. In this Q&A, Nicole Bitencourt, MD, highlights strategies that you can use to ensure that the...
Clifford Rosen, MD, chair of the Endocrine Society's 2019 clinical practice guideline for the pharmacological management of osteoporosis in postmenopausal women, reviews key points of the new...
Robyn Wiesel, MCHES, from Hospital for Special Surgery, answers our questions about the importance of self-management education programs for patients with rheumatic diseases and other chronic conditions. ...
Anniek M. van Roon, MD, PhD, answered our questions about the efficacy and feasibility of single-port thoracoscopic sympathicotomy among patients with treatment-resistant Raynaud phenomenon.
Yun Gao, MD, and Xiang Gao, MD, PhD, answer our questions about their research on the impact of the DASH diet on hyperuricemia in patients without gout.
Rohan Machhar and Dafna D. Gladman, MD, from the Krembil Research Institute, answer our questions about their research on microRNA-21-5p as a potential biomarker to predict which patients with psoriasis...
Atul Deodhar, MD, MRCP, from Oregon Health and Science University, answers our questions about the findings from the DISCOVER-1 clinical trial on the efficacy of guselkumab for the treatment of patients...
Jillian Rose, PhD, MPH, LCSW, and Priscilla Toral, LCSW, both from Hospital for Special Surgery, answer our questions about their research on self-reported needs and concerns of men with systemic lupus...
Sizheng Steven Zhao, MBChB(Hons), MRCP, from the University of Liverpool, answers our questions about his study that evaluated whether smoking has a protective effect from uveitis in patients with axial...
